A Double Blind, Placebo-controlled, Randomized, 15-day Treatment, Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil Administered Orally to Healthy Male Volunteers Including a Scopolamine Challenge
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 07 Nov 2019
Price : $35 *
At a glance
- Drugs THN-201 (Primary) ; Donepezil; Mefloquine
- Indications Cognition disorders
- Focus Pharmacodynamics
- Sponsors Theranexus
- 25 Sep 2019 Status changed from recruiting to active, no longer recruiting.
- 09 Sep 2019 Planned End Date changed from 31 Jul 2019 to 20 Dec 2019.
- 09 Sep 2019 Planned primary completion date changed from 30 Jun 2019 to 20 Oct 2019.